In another strategy, an oncolytic adenovirus, combined with a helper-dependent vector encoding a PD-L1-blocking mini-antibody, helped overcome T cell exhaustion and enabled effective tumor cell targeting by CAR-T cells [162]. This evidence concerns the gene CD274 and neoplasm.